Factors influencing the mutagenic activity of the colon carcinogen 1,2-dimethylhydrazine in Salmonella typhimurium strain TA 1535 in vitro.
The colon carcinogen 1,2-dimethylhydrazine (SMDH), a non-mutagen in the standard Ames assay, has been shown in previous experiments to become weakly mutagenic in Salmonella TA 1535 in vitro, when specific test conditions were used. The present studies were performed to determine more precisely the nature of metabolic factors and experimental conditions for optimal mutagenesis of SDMH in the same strain of Salmonella. First, it was confirmed that both the presence of rat liver S9 fractions (25 microliters/ml incubation mixture) and prolonged pre-incubation periods in liquid medium of at least 120 min were necessary to elicit SDMH mutagenesis. In contrast to results obtained with dimethylnitrosamine, which served as a model compound for the activation through oxidative, cytochrome P-450- and NADPH-dependent enzymatic processes, the activation of SDMH to mutagenic factors was not dependent on the presence of NADPH: in fact, NADPH strongly reduced the SDMH-induced mutation yields. It was also observed that growth of the indicator bacteria is an important prerequisite for mutation induction by SDMH. Aminoacetonitrile and disulfiram, two inhibitors of SDMH metabolism and carcinogenicity in mammals, also strongly inhibited SDMH mutagenesis in the present in vitro assay. It can, therefore, be concluded that (i) the right test protocol is of crucial importance for the detection of SDMH as a bacterial mutagen, and (ii) that activation pathways in vitro are (partially) different from presumed in vivo metabolism and activation.